Heart Disease News and Research

Latest Heart Disease News and Research

ULMCA PCI with DES a viable option for low-risk patients with normal left ventricular function

23 Jun 2011

Axxam receives ADDF grant to develop new therapeutics for Alzheimer's

The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it has awarded a grant to Axxam SpA to develop small molecules to treat Alzheimer's disease by targeting inflammation.

23 Jun 2011

CPDC, UHN to advance use of medical isotopes for cancer treatment and diagnosis

CanProbe, a unique, not-for-profit joint venture to advance the use of medical isotopes for diagnosing and treating cancer and other serious diseases, was announced today by the Centre for Probe Development and Commercialization (CPDC) and the University Health Network.

23 Jun 2011

AstraZeneca, Jubilant announce delivery outcomes and early success in Pain therapeutic area

Biosys Ltd., Bengaluru, based subsidiary of Jubilant Life Sciences Ltd., and AstraZeneca, today announced another successful delivery of an early stage milestone in the Pain therapeutic area.

23 Jun 2011

Study examines reasons for rise in cesarean delivery

In one of the first studies to examine the reasons for the rising number of women delivering their babies by cesarean section, Yale School of Medicine researchers found that while half of the increase was attributable to a rise in repeat cesarean delivery in women with a prior cesarean birth, an equal proportion was due to a rise in first time cesarean delivery.

23 Jun 2011

More frequent use of ultrasound recommended in twin pregnancies

Featured in the June edition of the Journal of Obstetrics and Gynaecology Canada is a new clinical practice guideline which suggests that carrying twins requires greater monitoring and, therefore, the more frequent use of ultrasound technology to conduct the ongoing assessment of twin pregnancies.

23 Jun 2011

Foods and lifestyles that cause most weight gain: Study

New research shows that eating more potato chips and French fries and watching too much TV are likely to lead to a bigger weight gain over the years than the weight change associated with eating more of other foods.

23 Jun 2011

High dose statins raise risk of diabetes: Study

According to the latest research taking a high-dose statin to lower cholesterol may increase risk of developing diabetes by as much as 12 percent, but the heart benefits of statins still outweigh the risks.

23 Jun 2011

First audio data of naturally occurring spanking of children

In one recording, a mom spanks her 3-year-old 11 times for fighting with his sister. In another, a mom slaps her son for turning the page of a book while she reads to him. In still another, a mom spanks her 5-year-old when he refuses to clean up his room after repeated warnings to do so.

23 Jun 2011

UCLA study reports favorable outcomes for angioplasty with stents for low-risk heart patients

Heart bypass surgery is considered the gold standard for most patients with left main coronary artery disease, one of the most serious types of heart disease and one that affects thousands.

23 Jun 2011

Sanofi Pasteur establishes new vaccine research and development facility in Canada

Mark Lievonen, President of Sanofi Pasteur Limited, and Premier Dalton McGuinty today opened a $101 million dollar vaccine research and development facility at Sanofi Pasteur's Connaught Campus in north Toronto. This new facility establishes the Connaught Campus as the North American Centre of Excellence in analytical and bioprocessing R&D for Sanofi Pasteur globally.

23 Jun 2011

Scientists find altering hormone levels change cellular development in brain

In a study that increases the understanding of the link between fetal development and obesity later in life, researchers at Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) found altering the levels of two common hormones, insulin and leptin, in utero changes the cellular development in the region of the brain that regulates appetite.

23 Jun 2011

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

Patients with normal left ventricular function who undergo elective unprotected left main coronary artery (ULMCA) percutaneous coronary intervention (PCI) with drug-eluting stents (DES) had favorable outcomes according to new research. Results of the multicenter, retrospective study are reported in the June issue of Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions (SCAI).

22 Jun 2011

Johns Hopkins cardiology chief becomes American Heart Association President

Gordon F. Tomaselli, M.D., professor and director of the Division of Cardiology at the Johns Hopkins University School of Medicine, will become president of the American Heart Association (AHA), the nation’s leading voluntary health organization focused on cardiovascular disease and stroke, on July 1.

22 Jun 2011

Angioplasty may be an option for liver transplant candidates with heart disease

A small, retrospective study determined that percutaneous coronary intervention (PCI) was safe in patients with significant coronary artery disease (CAD) who were referred for liver transplantation. Larger studies are needed to determine the effectiveness of angioplasty in patients with end-stage liver disease (ESLD). Details of the study are available in the July issue of Liver Transplantation, published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.

22 Jun 2011

New home for children's emergency care opens in upper Manhattan

The new Alexandra and Steven Cohen Pediatric Emergency Department at NewYork-Presbyterian Morgan Stanley Children's Hospital/Columbia University Medical Center opens tomorrow, Thursday, June 23, significantly expanding access to the highest level of emergency pediatric care for families in the region.

22 Jun 2011

New home for children's emergency care opens in upper Manhattan

22 Jun 2011

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

22 Jun 2011

Study finds PCI safe and feasible option for End-Stage Liver Disease patients with significant heart disease

22 Jun 2011

Tobira commences cenicriviroc Phase IIb clinical trial for HIV infection

Tobira Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies for HIV, announced today that it has initiated a Phase IIb clinical trial for the CCR5/CCR2 inhibitor cenicriviroc (TBR-652).

22 Jun 2011